Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
Clinical trial NCT02828033 · UNKNOWN
Trial details
- NCT number
- NCT02828033
- Sponsor
- Stanley Cohen
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.